AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Amanza MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Mcronus Lifescience Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Amanza MV 1mg/500mg/0.2mg Tablet

Diabeva-Trio 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This triple-combination therapy manages type 2 diabetes in adults by regulating blood glucose. Diabeva-Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before starting treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Amanza MV 1mg/500mg/0.2mg Tablet

The provided text is "undefined," which cannot be rephrased while maintaining meaning and length. There is no text to rewrite.

Uses of Amanza MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Amanza MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Amanza MV 1mg/500mg/0.2mg Tablet should be administered on an empty stomach.

Common Side effects of Amanza MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Amanza MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Amanza MV 1mg/500mg/0.2mg Tablet on an empty stomach.

How Amanza MV 1mg/500mg/0.2mg Tablet works:

Each Amanza MV tablet (1mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Amanza MV 1mg/500mg/0.2mg Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Amanza MV 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Amanza MV 1mg/500mg/0.2mg Tablet while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Amanza MV 1mg/500mg/0.2mg tablets is likely inadvisable for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, its use is contraindicated in patients exhibiting severe renal dysfunction.

LiverLiverCAUTION

Individuals with liver impairment should use Amanza MV 1mg/500mg/0.2mg Tablet cautiously. Dosage modification may be necessary. Physician consultation is advised. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Amanza MV 1mg/500mg/0.2mg Tablet :

Should you forget to take your Amanza MV 1mg/500mg/0.2mg Tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Amanza MV 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Amanza MV 1mg/500mg/0.2mg Tablet

Amanza MV 1mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 DM.
Amanza MV 1mg/500mg/0.2mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infections.
Amanza MV 1mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any component, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Amanza MV 1mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Amanza MV 1mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Amanza MV 1mg/500mg/0.2mg...
94
MRP 115
18% off